4
Archived articleThis is an archived article from 2015 - please note that any content within the article may be out of date.

Weekend Reading 6 February

Warren BuffettWarren Buffett's annual letter to Berkshire Hathaway shareholders tends to be hotly anticipated by investors everywhere. Apparently, it will arrive later this month together with two extra letters, one from Buffett and one from his business partner Charlie Munger, on their vision for Berkshire in the years ahead. Stephen Foley in the FT wrote an interesting preview of what we might expect, plus there's a great piece by Seth Klarman on the lessons that Buffett has taught us.

Topping Klarman's list of lessons is: “Value investing works. Buy bargains." And with that in mind, this week we had a look at how to build a deep value investing strategy. Also on the site, our CEO Ed Croft provoked a lot of discussion with his article on Michael Mauboussin's latest research about whether to buy, sell or hold after a large price drop.

Webinar alert!

Just a quick reminder that Ed will be holding a 45 minute webinar and 15 minute Q&A about some new site feature releases related to the StockRanks. We're launching an entirely new tab at the top of the site that is dedicated 100% to the StockRanks. The webinar is set for Tuesday 10th February at 12.30pm. Spaces are limited so please do book your seat early.

Stick to the factors…

Last week we mentioned that John Authers had picked up on the growing popularity of factor investing - something that we eulogise here at Stockopedia. This week there was a great article by Ben Carlson at A Wealth of Common Sense about whether this growing popularity will eventually damage returns. There's a lot of quotable stuff in there, but we liked this:

“Everyone now knows that buying cheap or high quality stocks works if you're patient. Most people aren't patient. Therein lies your edge as an investor."  

This article from systematic fund investor Euclidean on why value investing is so difficult, says pretty much the same thing. And on this note we are reminded of James Montier's classic “Ode to Quant" ended with the following two reasons why the majority of the investment industry isn't about to switch to factor based investing processes:

“Firstly, the fear of technological unemployment. If, say, 18 out of every 20 analysts and fund managers could be replaced by a computer, the results are unlikely to be welcomed by the industry at large. Secondly, the industry has a large dose of inertia contained within it. It is pretty inconceivable for a large fund management house to turn around and say they are scrapping most of the processes they had used for the last 20 years, in order to implement a quant model instead."

These kinds of behavioural and institutional underpinnings are why we have great faith that our 'factor' based StockRanks system may well continue to beat the market for a long time to come.

Europe a buy?

In investing, the FT's John Authers interviews a Citibank analyst who thinks European stocks are a buy. If so Stockopedia's European edition is the perfect sidekick - we've got 8,000+ European stocks in the edition from Amsterdam to Zagreb - have a look in the directory for starters - as Ed will show in Tuesday's webinar the StockRanks have been working brilliantly all across Europe.  

Stockopedia's small-cap expert Paul Scott wrote up some strong performers, including Amino Technologies and Character. And over on Interactive Investor, Lee Wild covered 10 shares to give you a £10,000 annual income.

Seen, not herd...

Finally, we've developed a habit for throwing a bit of behavioural finance theory into our Weekend Reading columns. So this week we're serving up an article by Carl Richards on some thought-provoking ideas about why standing out from the herd has become a much safer option than it used to be.

Safe Investing!


Disclaimer

This is not financial advice. Our content is intended to be used and must be used for information and education purposes only. Please read our disclaimer and terms and conditions to understand our obligations.

2 comments


Avatar for snickers

I noticed that iShares have started up some 'factor investing' etfs.
IEFM iShares MSCI Europe Momentum Factor
IEFV iShares MSCI Europe Value Factor ..novartis, sanofi, tesco, hsbc, imp tobacco, daimler, siemens, bp, bayer, vod, rio, barc, volkswagen, 30% UK, 20% germany, 20% france, 10% swiss..
IEFS iShares MSCI Europe Size Factor
IEFQ iShares MSCI Europe Quality Factor ..which is 25% financial, otw balanced. 45% UK, 15% swiss, 10% germany. novo nordisk, roche, BG, BAT, allianz, prudential, sap stamm, zurich, unilever, diageo.

so that's covered the Quant and the Europe parts of the article above. For the Behavioural part, while there's no immediate re-run of the following course: https://www.coursera.org/course/accounting it's worth finding out about and investigating, and study is a good way to keep your itchy fingers away from the buy button. This course was actually pretty entertaining.

1
Avatar for Edward Croft

Hey snickers... ETFs are a cheap way to get exposure to parts of the market. Of course the biggest problem with them is they have a tendency to be market cap weighted. These kinds of products have to build economies of scale that only work with market cap weighting.

So you actually are buying a lot of exposure to mega caps, rather than a lot of exposure to factors. There's a great paper by Soc Gen on this... the only way to get the full exposure to factors is to equal weight... and that's too expensive for most funds' business models.

DIY is definitely the way forwards !

0
Get the free newsletter